Evidence map›Paper›PMID 31214507›Full record

ArticleFrontiers in oncology2019

FLT-PET-CT for the Detection of Disease Recurrence After Stereotactic Ablative Radiotherapy or Hyperfractionation for Thoracic Malignancy: A Prospective Pilot Study.

Susan M Hiniker, Quaovi Sodji, Andrew Quon, Paulina M Gutkin, Natasha Arksey, Edward E Graves, Frederick T Chin, Peter G Maxim, Maximilian Diehn, Billy W Loo

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021
    Trial
  2. Review
  3. Impact of [Diagnostics (Basel, Switzerland) · 2021
    Article
  4. Precision radiotherapy for non-small cell lung cancer.Journal of biomedical science · 2020
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Susan M HinikerDepartment of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, United States.
Quaovi SodjiDepartment of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, United States.
Andrew QuonDepartment of Nuclear Medicine, Stanford University School of Medicine, Stanford, CA, United States.
Paulina M GutkinDepartment of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, United States.
Natasha ArkseyDepartment of Nuclear Medicine, Stanford University School of Medicine, Stanford, CA, United States.
Edward E GravesDepartment of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, United States.
Frederick T ChinDepartment of Nuclear Medicine, Stanford University School of Medicine, Stanford, CA, United States.
Peter G MaximDepartment of Radiation Oncology, Indiana University, Indianapolis, IN, United States.
Maximilian DiehnDepartment of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, United States.
Billy W LooDepartment of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, United States.
Stanford University · USIndiana University – Purdue University Indianapolis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Differentiating local recurrence from post-treatment changes on PET scans following stereotactic ablative radiotherapy (SABR) or hyperfractionation for lung tumors is challenging. We performed a prospective pilot study of 3-deoxy-3-[

Indexed as

3-deoxy-3-[18F]-fluorothymidinedisease recurrencepositron emission tomographystereotactic ablative radiotherapythoracic malignancy

Identifiers

PMID31214507
PMCPMC6555304
OpenAlexW2947647757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.